SCHEMBL5594797

SCHEMBL5594797

CCCOC(=O)N(OCCC)C(C(C)O)C(Cl)c1ccncc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ CYP19A1 P11511 2/20 0.33
▸ PKM P14618 1/20 0.32
▸ MAPT P10636 3/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ USP2 O75604 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ NAMPT P43490 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ ROCK1 Q13464 2/20 0.30
▸ ROCK2 O75116 1/20 0.30
▸ DYRK3 O43781 1/20 0.30
▸ PRKACA P17612 1/20 0.30
▸ RPS6KB1 P23443 1/20 0.30
▸ CDK2 P24941 1/20 0.30
▸ AKT2 P31751 1/20 0.30
▸ GSK3A P49840 1/20 0.30
▸ GSK3B P49841 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3365232 0.71 CYP19A1 (0.34) KDM4EALDH1A1ALOX15CYP19A1MAPT
SCHEMBL3369602 0.69 CYP19A1 (0.36) ALDH1A1CYP19A1MAPTNPC1USP2
SCHEMBL7148689 0.65 CHRNB2 (0.34) ALDH1A1
SCHEMBL755729 0.65 CYP19A1 (0.54) ALDH1A1CYP19A1PKMMAPTNAMPT
SCHEMBL5720902 0.61 CYP19A1 (0.42) KDM4EALDH1A1ALOX15CYP19A1NPC1
N-Propyl Isonicotinate SCHEMBL4951536 0.60 LMNA (0.67) KDM4EALDH1A1MAPTNPC1USP2
Bromide SCHEMBL10913811 0.59 NAMPT (0.43) KDM4EALDH1A1CYP19A1PKMMAPT
SCHEMBL9648777 0.59 MAPT (0.42) MAPT
SCHEMBL4192926 0.59 LMNA (0.55) ALDH1A1GAAKMT2A
N-Propyl Isonicotinate SCHEMBL28467485 0.59 LMNA (0.65) KDM4EALDH1A1MAPTNPC1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1575486-A4 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS GILEAD SCIENCES INC (US) 2007-02-28 — — EP disclosed
EP-1711617-A1 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTICS COMPOUNDS GILEAD SCIENCES, INC. (US) 2006-10-18 — — EP disclosed
WO-2005064008-A9 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS GILEAD SCIENCES INC (US) 2006-09-28 — — WO disclosed
EP-1620445-A2 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS GILEAD SCIENCES, INC. (US) 2006-02-01 — — EP disclosed
EP-1575486-A2 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS GILEAD SCIENCES, INC. (US) 2005-09-21 — — EP disclosed
WO-2005064008-A1 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS GILEAD SCIENCES, INC. (US) 2005-07-14 — — WO disclosed
EP-1509537-A2 CELLULAR ACCUMULATION OF PHOSPHONATE ANALOGS OF HIV PROTEASE INHIBITOR COMPOUNDS AND THE COMPOUNDS AS SUCH GILEAD SCIENCES, INC. (US) 2005-03-02 — — EP disclosed
WO-2004096818-A2 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS GILEAD SCIENCES, INC. (US) 2004-11-11 — — WO disclosed
WO-2003090691-A2 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS GILEAD SCIENCES, INC. (US) 2003-11-06 — — WO disclosed
WO-2003090690-A2 CELLULAR ACCUMULATION OF PHOSPHONATE ANALOGS OF HIV PROTEASE INHIBITOR COMPOUNDS AND THE COMPOUNDS AS SUCH GILEAD SCIENCES, INC. (US) 2003-11-06 — — WO disclosed
Send feedback